by Rod D. Martin
July 17, 2013
This morning, Tobin Smith named our Galectin Therapeutics the “Next Big Thing” in fibrosis and cancer treatment. I absolutely agree, and appreciate the coverage. This little company may well change the world and save millions of lives, and we have certainly fought hard to get here.
— Rod D. Martin (@RodDMartin) July 17, 2013
— Tobin Smith (@tobinsmith) July 17, 2013